INM Stock Overview
InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
InventionMed S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.21 |
| 52 Week High | zł0.35 |
| 52 Week Low | zł0.12 |
| Beta | 0.16 |
| 1 Month Change | -7.11% |
| 3 Month Change | -15.73% |
| 1 Year Change | 67.87% |
| 3 Year Change | 12.37% |
| 5 Year Change | -47.75% |
| Change since IPO | -86.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| INM | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -5.0% | -1.2% | 3.5% |
| 1Y | 67.9% | -6.5% | 27.4% |
Return vs Industry: INM exceeded the Polish Medical Equipment industry which returned -6.5% over the past year.
Return vs Market: INM exceeded the Polish Market which returned 27.4% over the past year.
Price Volatility
| INM volatility | |
|---|---|
| INM Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in PL Market | 9.6% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: INM's share price has been volatile over the past 3 months.
Volatility Over Time: INM's weekly volatility has decreased from 13% to 6% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 7 | Tomasz Kierul | inventionmed.com |
InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. Its flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. The company also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology.
InventionMed S.A. Fundamentals Summary
| INM fundamental statistics | |
|---|---|
| Market cap | zł42.38m |
| Earnings (TTM) | -zł2.46m |
| Revenue (TTM) | zł605.00 |
Over9,999x
P/S Ratio-17.2x
P/E RatioIs INM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INM income statement (TTM) | |
|---|---|
| Revenue | zł605.00 |
| Cost of Revenue | zł10.90k |
| Gross Profit | -zł10.29k |
| Other Expenses | zł2.45m |
| Earnings | -zł2.46m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 28, 2024
| Earnings per share (EPS) | -0.012 |
| Gross Margin | -1,701.32% |
| Net Profit Margin | -406,527.77% |
| Debt/Equity Ratio | 43.4% |
How did INM perform over the long term?
See historical performance and comparison